| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701108 | European Journal of Surgical Oncology (EJSO) | 2016 | 21 Pages |
Abstract
FNMTC is rare but can be diagnosed clinically. Its impact on prognostic factors and the subsequent role in influencing management is debated. For those patients who present with otherwise low-risk differentiated thyroid cancer, FNMTC should be included in risk assessment when discussing therapeutic options.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
I.J. Nixon, C. Suárez, R. Simo, A. Sanabria, P. Angelos, A. Rinaldo, J.P. Rodrigo, L.P. Kowalski, D.M. Hartl, M.L. Hinni, J.P. Shah, A. Ferlito,